• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清胱抑素 C 作为透析起始时终末期肾病患者心血管事件的预测因子。

Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

机构信息

Division of Nephrology, Department of Internal Medicine, Pusan National University Hospital School of Medicine, Busan, Republic of Korea.

出版信息

Clin Exp Nephrol. 2012 Jun;16(3):456-63. doi: 10.1007/s10157-011-0583-1. Epub 2012 Jan 26.

DOI:10.1007/s10157-011-0583-1
PMID:22278599
Abstract

BACKGROUND

There has been no study to investigate whether cystatin C could predict cardiovascular events in incident dialysis patients. We aimed to delineate the role of serum cystatin C and cystatin C-based estimated glomerular filtration rate (eGFR(cysC)) for prediction of cardiovascular events.

METHODS

This study included 66 end-stage renal disease patients who survived for >3 months after the start of dialysis, and serum cystain C levels were measured at the point of dialysis initiation.

RESULTS

Serum cystatin C was correlated with blood urea nitrogen (r = 0.537, p < 0.001), serum creatinine (r = 0.480, p < 0.001) and smoking (r = 0.284, p = 0.021). Cystatin C was inversely correlated with age (r = -0.316, p = 0.01) and eGFR(Cr) by modification of diet in renal disease (r = -0.533, p < 0.001). Kaplan-Meier analysis for cardiovascular events revealed that patients in the group with lower cystatin C levels (<4.14 mg/L) had a better event-free survival rate than patients in the group with higher cystatin C levels (≥4.14 mg/L) (p = 0.039). In univariate analysis, cystatin C (hazard ratio (HR) 2.62, p = 0.011) and eGFR(cysC) (HR 0.64, p = 0.004) were significant factors for the prediction of cardiovascular events. After multivariate adjustment, serum cystatin C and eGFR(cysC) were independent determinants of cardiovascular events (HR 3.952, p = 0.001 and HR 0.640, p = 0.004, respectively).

CONCLUSION

Serum cystatin C might be an independent marker of cardiovascular events in incident dialysis patients. Furthermore, eGFR(cysC) based on measured serum cystatin C could have a new role in predicting cardiovascular events beyond the estimation of true GFR.

摘要

背景

目前还没有研究调查胱抑素 C 是否可以预测新开始透析的患者的心血管事件。我们旨在描述血清胱抑素 C 和基于胱抑素 C 的估计肾小球滤过率(eGFR(cysC))在预测心血管事件中的作用。

方法

本研究纳入了 66 名在开始透析后存活超过 3 个月的终末期肾病患者,并在开始透析时测量血清胱抑素 C 水平。

结果

血清胱抑素 C 与血尿素氮(r = 0.537,p < 0.001)、血清肌酐(r = 0.480,p < 0.001)和吸烟(r = 0.284,p = 0.021)呈正相关。胱抑素 C 与年龄(r = -0.316,p = 0.01)和通过肾脏病饮食改良公式(MDRD)计算的 eGFR(r = -0.533,p < 0.001)呈负相关。心血管事件的 Kaplan-Meier 分析显示,胱抑素 C 水平较低(<4.14mg/L)组的患者无事件生存率高于胱抑素 C 水平较高(≥4.14mg/L)组(p = 0.039)。在单因素分析中,胱抑素 C(危险比(HR)2.62,p = 0.011)和 eGFR(cysC)(HR 0.64,p = 0.004)是预测心血管事件的显著因素。经过多因素调整后,血清胱抑素 C 和 eGFR(cysC)是心血管事件的独立决定因素(HR 3.952,p = 0.001 和 HR 0.640,p = 0.004)。

结论

血清胱抑素 C 可能是新开始透析患者心血管事件的独立标志物。此外,基于实测血清胱抑素 C 的 eGFR(cysC)除了估计真 GFR 外,在预测心血管事件方面可能具有新的作用。

相似文献

1
Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.血清胱抑素 C 作为透析起始时终末期肾病患者心血管事件的预测因子。
Clin Exp Nephrol. 2012 Jun;16(3):456-63. doi: 10.1007/s10157-011-0583-1. Epub 2012 Jan 26.
2
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.半胱氨酸蛋白酶抑制剂 C 可识别出处于不良心血管事件高危状态的稳定型慢性心力衰竭患者。
Circ Heart Fail. 2012 Sep 1;5(5):602-9. doi: 10.1161/CIRCHEARTFAILURE.112.966960. Epub 2012 Aug 16.
3
Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.在接受药物洗脱支架选择性经皮冠状动脉介入治疗后估计肾小球滤过率保留的患者中,胱抑素C水平升高作为心血管事件的危险因素。
Heart Vessels. 2016 May;31(5):694-701. doi: 10.1007/s00380-015-0674-0. Epub 2015 Apr 12.
4
Estimation of residual glomerular filtration rate in peritoneal dialysis patients using cystatin C: comparison with 51Cr-EDTA clearance.应用胱抑素 C 估算腹膜透析患者的残余肾小球滤过率:与 51Cr-EDTA 清除率的比较。
Nephrol Dial Transplant. 2011 Nov;26(11):3729-32. doi: 10.1093/ndt/gfr112. Epub 2011 Mar 25.
5
Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.半胱氨酸蛋白酶抑制剂 C 是一种敏感的标志物,可用于检测类风湿关节炎和继发性淀粉样变性患者慢性肾脏病时肾小球滤过率的降低。
Scand J Rheumatol. 2010;39(1):33-7. doi: 10.3109/03009740903042402.
6
Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease.基于肌酐和胱抑素 C 的血清指标可预测非透析慢性肾脏病患者的死亡率。
Sci Rep. 2021 Aug 19;11(1):16863. doi: 10.1038/s41598-021-96447-9.
7
Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes.基于肌酐和胱抑素 C 的肾功能定义在预测糖尿病患者主要心血管事件风险中的临床实用性。
Diabetes Care. 2012 Apr;35(4):879-86. doi: 10.2337/dc11-1998. Epub 2012 Feb 14.
8
Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus.血清胱抑素 C 与系统性红斑狼疮患者的肾功能相关,但与心血管危险因素或亚临床动脉粥样硬化无关。
Clin Rheumatol. 2017 Dec;36(12):2709-2717. doi: 10.1007/s10067-017-3837-9. Epub 2017 Sep 15.
9
Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index.根据体重指数类别,使用基于肌酐和胱抑素C的估算方程对慢性肾脏病进行差异估计。
Am J Kidney Dis. 2009 Jun;53(6):993-1001. doi: 10.1053/j.ajkd.2008.12.043. Epub 2009 Apr 25.
10
Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.胱抑素 C 是预测急性肝衰竭患者急性肾损伤的生物标志物。
World J Gastroenterol. 2013 Dec 28;19(48):9432-8. doi: 10.3748/wjg.v19.i48.9432.

引用本文的文献

1
Short-term blood pressure variability and outcomes in non-dialysis chronic kidney disease.非透析慢性肾脏病患者的短期血压变异性与预后
Front Med (Lausanne). 2022 Sep 27;9:911205. doi: 10.3389/fmed.2022.911205. eCollection 2022.
2
Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation.血清胱抑素C,一种肾功能和心血管疾病的敏感标志物,戒烟后会降低。
Circ Rep. 2019 Nov 30;1(12):623-627. doi: 10.1253/circrep.CR-19-0052.
3
GFR Estimation After Cystatin C Reference Material Change.

本文引用的文献

1
Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography.血清胱抑素 C 与多排螺旋 CT 检测早期冠状动脉粥样硬化斑块形态有关。
Atherosclerosis. 2011 Oct;218(2):350-5. doi: 10.1016/j.atherosclerosis.2011.06.046. Epub 2011 Jul 6.
2
Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target.胱抑素 C 在急性冠状动脉综合征中的预后价值:动脉粥样硬化的增强因子和有前途的治疗靶点。
Clin Chem Lab Med. 2011 Sep;49(9):1397-404. doi: 10.1515/CCLM.2011.607. Epub 2011 May 24.
3
Cystatin C is more than GFR, and this may be a good thing.
胱抑素C参考物质变更后的肾小球滤过率估算
Kidney Int Rep. 2020 Dec 7;6(2):429-436. doi: 10.1016/j.ekir.2020.11.028. eCollection 2021 Feb.
4
Cystatin C as a biomarker of chronic kidney disease: latest developments.胱抑素 C 作为慢性肾脏病的生物标志物:最新进展。
Expert Rev Mol Diagn. 2020 Oct;20(10):1019-1026. doi: 10.1080/14737159.2020.1768849. Epub 2020 May 25.
5
Association between renal damage markers and carotid atherosclerosis in Afro-descendants with hypertension belonging to a minority ethnic group from Brazil.巴西少数民族裔高血压患者的肾脏损伤标志物与颈动脉粥样硬化的关系。
Ren Fail. 2018 Nov;40(1):483-491. doi: 10.1080/0886022X.2018.1496932.
6
The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.采用改良的PDAY风险评分评估慢性肾脏病患儿中基于肌酐与胱抑素C的估算肾小球滤过率与心血管风险之间的关联。
Pediatr Nephrol. 2017 Aug;32(8):1457-1463. doi: 10.1007/s00467-017-3683-7. Epub 2017 May 8.
7
Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.重新审视尿毒症毒性的中分子假说:β2微球蛋白群体动力学的系统评价及血液透析试验的大规模计算机模拟
PLoS One. 2016 Apr 7;11(4):e0153157. doi: 10.1371/journal.pone.0153157. eCollection 2016.
8
Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy.血清胱抑素 C 浓度作为高血压左心室肥厚的独立标志物。
J Geriatr Cardiol. 2013 Sep;10(3):286-90. doi: 10.3969/j.issn.1671-5411.2013.03.001.
9
Cystatin C in children on chronic hemodialysis.儿童慢性血液透析患者胱抑素 C。
Pediatr Nephrol. 2013 Apr;28(4):647-53. doi: 10.1007/s00467-012-2366-7. Epub 2012 Nov 21.
10
Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant.点突变对人胱抑素 C 及其 L68Q 变体的稳定性、二聚化和寡聚化的影响。
Front Mol Neurosci. 2012 Jul 27;5:82. doi: 10.3389/fnmol.2012.00082. eCollection 2012.
胱抑素C不仅仅反映肾小球滤过率,而这可能是件好事。
J Am Soc Nephrol. 2011 May;22(5):795-7. doi: 10.1681/ASN.2011030288. Epub 2011 Apr 14.
4
Association between serum cystatin C, monocytes and other inflammatory markers.血清胱抑素 C、单核细胞与其他炎症标志物的关系。
Intern Med J. 2012 May;42(5):517-22. doi: 10.1111/j.1445-5994.2011.02500.x.
5
Estimated GFR associates with cardiovascular risk factors independently of measured GFR.估算的肾小球滤过率与心血管风险因素相关,而不依赖于实测的肾小球滤过率。
J Am Soc Nephrol. 2011 May;22(5):927-37. doi: 10.1681/ASN.2010050479. Epub 2011 Mar 31.
6
Cystatin C identifies chronic kidney disease patients at higher risk for complications.胱抑素 C 可识别出发生并发症风险较高的慢性肾脏病患者。
J Am Soc Nephrol. 2011 Jan;22(1):147-55. doi: 10.1681/ASN.2010050483. Epub 2010 Dec 16.
7
Association between cystatin C and inflammation in patients with essential hypertension.胱抑素 C 与原发性高血压患者炎症的关系。
Clin Exp Nephrol. 2010 Dec;14(6):584-8. doi: 10.1007/s10157-010-0334-8. Epub 2010 Aug 31.
8
Clinical utility of serum cystatin C in predicting coronary artery disease.血清胱抑素 C 在预测冠状动脉疾病中的临床应用。
Cardiol J. 2010;17(4):374-80.
9
Cathepsins and cystatin C in atherosclerosis and obesity.组织蛋白酶和胱抑素 C 在动脉粥样硬化和肥胖中的作用。
Biochimie. 2010 Nov;92(11):1580-6. doi: 10.1016/j.biochi.2010.04.011. Epub 2010 Apr 24.
10
Method of glomerular filtration rate estimation affects prediction of mortality risk.肾小球滤过率估算方法影响死亡风险预测。
J Am Soc Nephrol. 2009 Oct;20(10):2214-22. doi: 10.1681/ASN.2008090980. Epub 2009 Sep 17.